| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| R&D Expense | $26.9M | +320.1% |
| SG&A Expense | $9.7M | -7.8% |
| Operating Income | -$210.9M | -847.3% |
| Pre-tax Income | -$209.8M | -880.4% |
| Income Tax | $50K | +22.0% |
| Net Income | -$209.8M | -878.8% |
| EPS (Basic) | $3.98 | +121.5% |
| EPS (Diluted) | $3.98 | +121.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $257.6M | +1717.5% |
| Current Assets | $260.4M | +1446.5% |
| Total Assets | $260.5M | +1420.7% |
| Current Liabilities | $20.1M | +1576.4% |
| Total Liabilities | $20.1M | +1448.6% |
| Stockholders' Equity | $240.4M | +1418.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$6.7M | +63.9% |
| Investing Cash Flow | -$17.4M | -249.1% |
| Financing Cash Flow | $266.8M | — |